What Did Big Pharma Earnings Say About China Growth?
This article was originally published in PharmAsia News
Executive Summary
Moving from a mixed to a more pessimistic outlook, top executives at multinational drug firms see China as fast losing its shine, despite the country continuing to lead growth in the emerging markets. PharmAsia News has combed through quarterly earnings reports to bring you the winners, laggards and most successful growth strategies in this increasingly challenging market.